https://orcid.org/0000-0002-0116-749X
Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Sushmaa Chandralekha Selvakumar, K Auxzilia Preethi, Deepak Nallaswamy Veeraiyan & Durairaj Sekar. (2022) The role of microRNAs on the pathogenesis, diagnosis and management of portal hypertension in patients with chronic liver disease. Expert Review of Gastroenterology & Hepatology 16:10, pages 941-951.
Read now
Read now
Xiaoqiang Hu, Junzhe Zhang, Junfeng Bu, Kaini Yang, Sunwang Xu, Mengqiao Pan, Dongxi Xiang & Wei Chen. (2022) MiR-4733-5p promotes gallbladder carcinoma progression via directly targeting kruppel like factor 7. Bioengineered 13:4, pages 10691-10706.
Read now
Read now
Yasi Xing, Xinfa Zhang, Fangyuan Qin, Jingwen Yang, Lei Ai, Qingsong Wang & Yaping Zhai. (2022) The clinical significance of circulating tumor cells and T lymphocyte subtypes in pancreatic cancer patients. Bioengineered 13:2, pages 2128-2136.
Read now
Read now
Xiaobin Chi, Yi Jiang, Yongbiao Chen, Lizhi Lv, Jianwei Chen, Fang Yang, Xiaojin Zhang, Fan Pan & Qiucheng Cai. (2021) Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion. Bioengineered 12:1, pages 7519-7528.
Read now
Read now
Articles from other publishers (7)
Mehrdad Hashemi, Pouria Daneii, Mahya Asadalizadeh, Kiana Tabari, Arash Matinahmadi, Seyed Shahabadin Bidoki, Yasamin Sadat Mousavi Motlagh, Ali Moghadas Jafari, Amin Ghorbani, Amir Dehghanpour, Noushin Nabavi, Shing Cheng Tan, Mohsen Rashidi, Afshin Taheriazam, Maliheh Entezari & Mohammad Ali Sheikhbeig Goharrizi. (2024) Epigenetic regulation of hepatocellular carcinoma progression: microRNAs as therapeutic, diagnostic and prognostic factors. The International Journal of Biochemistry & Cell Biology, pages 106566.
Crossref
Crossref
Alina-Veronica Ghionescu, Andrei Sorop & Simona Olimpia Dima. (2023) The pivotal role of EMT-related noncoding RNAs regulatory axes in hepatocellular carcinoma. Frontiers in Pharmacology 14.
Crossref
Crossref
Kimia Karimi, Sarah Mojtabavi, Pooya M. Tehrany, Melina Maghsodlou Nejad, Aryan Rezaee, Shahab Mohtashamian, Erfan Hamedi, Farnaz Yousefi, Farshid Salmani, Mohammad Arad Zandieh, Noushin Nabavi, Navid Rabiee, Yavuz Nuri Ertas, Shokooh Salimimoghadam, Mohsen Rashidi, Parham Rahmanian, Kiavash Hushmandi & Wei Yu. (2023) Chitosan-based nanoscale delivery systems in hepatocellular carcinoma: Versatile bio-platform with theranostic application. International Journal of Biological Macromolecules 242, pages 124935.
Crossref
Crossref
Yong Peng, Jianhua Cui, Kaiwen Ma & Xi Zhong. (2023)
Hsa_circ_0005273 acts as a sponge of
miR
‐509‐3p to promote the malignant behaviors of breast cancer by regulating
HMMR
expression
. Thoracic Cancer 14:9, pages 794-804.
Crossref
Crossref
Zhao-Shan Niu, Wen-Hong Wang & Xiao-Jun Niu. (2022) Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma. World Journal of Gastroenterology 28:46, pages 6433-6477.
Crossref
Crossref
Yiyu Qin, Mingdi Zhang, Haiming Lei, Hongyan Wu, Cheng Huang, Xin Zhou, Yang Fu, Mingzhe Weng & Mingzhe Ma. (2022) Knockdown of IGF2BP3 inhibits the tumorigenesis of gallbladder cancer and modifies tumor microenvironment. Drug Development Research 83:8, pages 1831-1844.
Crossref
Crossref
Xuanfeng Zhang, Dong Zhang, Xuefeng Bu, Xinhui Zhang & Long Cui. (2022) Identification of a novel miRNA-based recurrence and prognosis prediction biomarker for hepatocellular carcinoma. BMC Bioinformatics 23:1.
Crossref
Crossref